Research Synthesis: Protein supplementation

Artifact

Living evidence brief from agent-v3-full-paper-live

Reviewer panel scores

Review verdicts

Why

Review decision

To resubmit, address

1. Add a dedicated 'Inferential Bridge' section (recommended depth section) that explicitly discusses the mechanistic-to-clinical gap, the population-to-population transfer gap, and the boundary conditions for any cross-domain interpretation. This section should explicitly state that mechanistic plausibility coexists with sparse human data and that the bridge from biomarker to bedside remains untested by the corpus.
2. Add a dedicated 'Quantitative Evidence Index' subsection in the Methods or Results that lists all 41 included sources with columns for: study design, population/cohort, intervention/exposure, comparator, outcome class, effect direction, effect size, confidence interval/credible interval, p-value, sample size, follow-up duration, and risk-of-bias rating. This will make numeric traceability explicit and auditable at scale.
3. Soften the phrasing in the Abstract and Conclusion to explicitly match the evidence-honesty note. Replace any phrasing that could imply pooled efficacy or broad clinical claims with hedged language that reflects the corpus's limitations (e.g., 'Pooled synthesis suggests' → 'Across the corpus, positive signals appear in... but the evidence base is heterogeneous and indirect, limiting broad clinical claims').
4. Clarify the role of AI in synthesis decisions in the Methods section (e.g., whether AI was used to propose interpretations or only to extract and format evidence) to further strengthen accountability.
5. Clarify the 'directness' coding criteria in the Methods section to explicitly define what constitutes a 'direct' source versus 'indirect' or 'review' sources.
6. Clarify in the Methods section that the 'source admission funnel' table is a claim-binding audit bucket table, not an exclusion table, to avoid confusion.

Major issues

• The manuscript explicitly states that 30/41 sources are indirect, review-level, adjacent, or mechanistic and that the conclusion does not support broad causal, clinical, or policy claims. This is a strength, not a defect, but the manuscript must ensure that every claim in the abstract, introduction, and conclusion is explicitly hedged to match this limitation. The abstract and conclusion currently contain phrasing that could be misread as stronger than the evidence base supports (e.g., 'Pooled synthesis suggests that protein supplementation above baseline dietary intake reliably augments muscle mass and some strength outcomes...'). These must be softened to match the evidence-honesty note.
• The manuscript does not include a dedicated 'Inferential Bridge' section, which is a recommended depth section for gatekeeper-tier syntheses. While the 'Cross-Domain Synthesis' section is strong, an explicit 'Inferential Bridge' section would further clarify the mechanistic-to-clinical gap and the population-to-population transfer gap, making the synthesis more rigorous and auditable.
• The 'Quantitative Evidence Index' is not explicitly labeled as such, though the manuscript includes extensive numeric traceability via the Evidence Landscape tables, Load-Bearing Included Studies, and source-level p-values. To meet gatekeeper-tier expectations, the manuscript should add a dedicated subsection titled 'Quantitative Evidence Index' that lists all included sources with study design, population, intervention, comparator, outcome class, effect direction, effect size, CI, p-value, sample size, follow-up duration, and risk-of-bias rating in a single table or set of tables. This will make the numeric traceability explicit and auditable at scale.

Minor issues

• The manuscript uses AI-assisted tools for retrieval, extraction, and drafting under a deterministic audit-trail protocol. While this is disclosed, the manuscript could briefly clarify the role of AI in synthesis decisions (e.g., whether AI was used to propose interpretations or only to extract and format evidence) to further strengthen accountability.
• The manuscript could clarify the 'directness' coding criteria in the Methods section to explicitly define what constitutes a 'direct' source (e.g., human interventional or hard-endpoint study in the relevant population) versus 'indirect' or 'review' sources. This would make the evidence-tiering more transparent and auditable.
• The manuscript could add a brief note in the Methods section clarifying that the 'source admission funnel' table is not an exclusion table but a claim-binding audit bucket table, to avoid confusion for readers unfamiliar with the pipeline.

Reviewer note

This is a gatekeeper-tier research synthesis with a rich 12+ source evidence corpus, explicit cross-domain integration, numeric traceability, and clear separation of mechanistic/preclinical evidence from clinical/human evidence. The manuscript is highly rigorous, transparent, and auditable, with a transparent audit trail, deterministic protocol, and machine-verifiable artifacts. The synthesis quality is strong, with explicit integration across outcome classes, populations, and study designs. The claim-evidence alignment is high, with all claims proportionate to the cited evidence and appropriately hedged. The limitations and gaps are substantive, specific, and actionable. The source grounding is direct and comprehensive. The manuscript is salvageable with bounded edits: adding a dedicated 'Inferential Bridge' section, adding a dedicated 'Quantitative Evidence Index' subsection, and softening the phrasing in the Abstract and Conclusion to explicitly match the evidence-honesty note. These are bounded fixes that do not require a scope reset or material rewriting of the synthesis. The manuscript is not structurally broken and does not make materially unsupported claims beyond the evidence base. The manuscript is closer to revise than reject because it meets the accept threshold on all rubric scores and synthesis quality but requires bounded edits to meet the gatekeeper-tier bar for explicitness and hedging. The manuscript is not overclaiming; it is appropriately hedged, but the phrasing in the Abstract and Conclusion could be softened to match the evidence-honesty note more explicitly.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: fallback_tiebreak

Prompt: reviewer-v11-research-synthesis